Andrea Necchi
@andreanecchi
Associate Professor @MyUniSR - Director of Genitourinary Medical Oncology @SanRaffaeleMI - Vice President @GTumors - Associate Editor @JCO_ASCO
ID: 547064288
http://www.andreanecchi.com 06-04-2012 19:53:04
2,2K Tweet
3,3K Followers
947 Following
Optimizing next-gen sequencing in #Urothelial cancer - #Expert #Consensus recommendations! Andrea Necchi and Ashish M. Kamat, MD, MBBS underscore the need for careful tissue mgmt, recommending NGS especially when clinical trial opportunities are present. #WatchNow > bit.ly/46HB8nJ
Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and Management Eur Urol Focus Sarah P. Psutka MD MS Philippe spiess Global Society of Rare GU Tumors eu-focus.europeanurology.com/article/S2405-…
Cannabis for Refractory Chemotherapy-Induced Nausea and Vomiting: the applicability and generalizability of the evidence is limited by changes in antiemetic guidelines and availability of THC:CBD. Thoughtful Journal of Clinical Oncology editorial by Dr Zimmermann ascopubs.org/doi/full/10.12…
What’s the difference between urachal and nonurachal adenocarcinoma the bladder? You may take a look of this most recent paper published this month in JCO Precision Oncology JCO Precision Oncology This important study, led by Dr. Andea Necchi Andrea Necchi, represents the largest cohort
Neoadjuvant sacituzumab govitecan shows promising activity in muscle-invasive urothelial bladder cancer. Watch Dr Antonio Cigliola discuss the SURE-01/02 study👉 bit.ly/3AZkofG Ospedale San Raffaele #ASCO2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: use of large language models required 9 seconds/chart versus 15 minutes for clinician adjudication and demonstrated higher sensitivity with similar specificity. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…
Huge congrats to prof. Andrea Necchi and all the team, stellar first author Chiara Mercinelli and my partner in crime Laura Cogrossi